HEPTbeta AS A TARGET IN TREATMENT OF ANGIOGENISIS MEDIATED DISORDERS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

12610843

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein is the use of HPTPbeta to screen agents useful in the treatment angiogenesis mediated disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AERPIO PHARMACEUTICALS INC9987 CARVER ROAD SUITE 420 CINCINNATI OH 45242

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Davis, Michael Glen Lebanon, US 3 155
Peters, Kevin Gene Pennington, US 31 793

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation